If you are part of an early-stage life science company or an academic team, collaboration with a large corporate partner may be critical to successfully bring your innovative pharmaceutical and digital therapeutic to patients. Such a partnership or collaboration may give you access to research, commercialisation or regulatory expertise, as well as resources and networks which are otherwise hard to tap into.

When startups and academic groups explore potential partnerships, this usually starts with a scientific exchange of non-confidential information. It is essential to show enough data to get the potential partner interested, while carefully considering what information to keep confidential to retain value for the project. During this program, participants will look at non-confidential data sharing, including how potential partners review and evaluate opportunities based on this information and how innovators might present their data in a different way depending on the audience.

Early innovators, academic researchers, and entrepreneurs are welcome to register here.

Stakeholders supporting these startups are also welcome.